The global anticancer drugs market size is calculated at USD 182.37 billion in 2025 and is expected to reach around USD ...

The positive phase II study data prompted Vanda to look at a phase III study of the neurokinin-1 receptor antagonist next year. Also, the U.S. Supreme Court decided to not review a case about the U.S.

St. Jude Children’s Research Hospital® and ALSAC, its fundraising and awareness organization, announced today that two new ...

Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...